Smart drugs are as a dangerous model of psychoactive substance use

When examining the factors of the use of psychoactive substances (PAS) by young people, recreational consumption has traditionally been studied. The second well-known causal model to examine psychoactive substances was its interpretation as a way of coping with stress for persons with a limited number of adaptation strategies. But data from foreign studies show the development of a new practice of consumption of stimulants, including permitted drugs, in order to improve mental productivity, performance, and improve cognitive function. The pace of life, loads, complex tasks that have to be solved in adolescence are increasing. In conjunction with the models of social behavior influencing the modern young persons, with the cult of success, achievements, perfectionist attitudes, this creates the motivation for self-improvement. And unless ways of improving the body have repeatedly become the topic of scientific researches and publications, the desire to improve the one's own brain function stays in the shadows, it has not yet attracted attention of Russian specialists and needs to be studied. The article analyzes the data of empirical studies that indicate an increase in the consumption of nootropics and other stimulants by students to achieve academic success.

1. Antinarkoticheskaya politika sovremennoi Rossii [Anti-drug policy of modern Russia: dictionary-reference]: Slovar'-spravochnik. 2-e izd., pererab. i dop. Eds. A.V. Mal'ko [et al.]. Moscow: Prospekt, 2017. 352 p. (In Russ.).
2. Voronina T.A., Seredenin S.B. Nootropnye i neiroprotektornye sredstva [Nootropes (cognition enhancers) and neuroprotectors]. Eksperimental'naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology, 2007. Vol. 70, no. 4, pp. 44–58. DOI:10.30906/0869-2092-2007-70-4-44-58 (In Russ.).
3. Garanyan N.G., Andrusenko D.A., Khlomov I.D. Perfektsionizm kak faktor studencheskoi dezadaptatsii [Elektronnyi resurs] [Perfectionism as a factor of student disadaptation]. Psikhologicheskaya nauka i obrazovanie = Psychological Science and Education, 2009. Vol. 1, pp. 72–82. URL: https://psyjournals.ru/files/19536/psyedu_2009_n1_Garanyan_Andrusenko_Hlomov.pdf (Accessed 10.06.2021). (In Russ.).
4. Milekhin A.V., Umnyashova I.B., Egorov I.A. Psikhologo-pedagogicheskie usloviya pervichnoi profilaktiki v studencheskoi srede [Psychological and Educational Prerequisites for Primary Prevention of Drug Addiction among Students]. Psikhologiya i parvo = [Psychology and Law], 2020. Vol. 10, no. 4, pp. 111–125. DOI:10.17759/psylaw.2020100408 (In Russ.).
5. Sirota N.A., Yaltonskii V.M. Effektivnye programmy profilaktiki zavisimosti ot narkotikov i drugikh form zavisimogo povedeniya [Effective programs for the prevention of drug dependence and other forms of dependent behavior]. Moscow: OOO «Tsentr poligraficheskikh uslug Raduga», 2004. 192 p. (In Russ.).
6. Kholmogorova A.B., Garanyan N.G., Tsatsulin T.O. Dinamika pokazatelei perfektsionizma i simptomov emotsional'nogo neblagopoluchiya v rossiiskoi studencheskoi populyatsii za poslednie desyat' let: kogortnoe issledovanie [Dynamics of Indicators of Perfectionism and Symptoms of Emotional Distress in the Russian Student Population over the Past Ten Years: Cohort Study]. Kul'turno-istoricheskaya psikhologiya = Cultural-Historical Psychology, 2019. Vol. 15, no. 3, pp. 41–50. DOI:10.17759/chp.2019150305 (In Russ.).
7. Schelle K.J. et al. Attitudes toward pharmacological cognitive enhancement: a review. Frontiers in Systems Neuroscience, 2014. Vol. 8, 15 p. DOI:10.3389/fnsys.2014.00053
8. Bagot K.S., Kaminer Y. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction, 2014. Vol. 109, no. 2, pp. 547–557. DOI:10.1111/add.12460
9. Battleday R.M., Brem A.K. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. European Neuropsychopharmacology, 2015. Vol. 25, no. 11, pp. 1865–1881. DOI:10.1016/j.euroneuro.2015.07.028
10. Mackenzie C.S. et al. Changes in attitudes toward seeking mental health services: A 40-year cross-temporal meta-analysis. Clinical Psychology Review, 2014. Vol. 34, no. 2, pp. 99–106. DOI:10.1016/j.cpr.2013.12.001
11. DuPont R.L. et al. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. American Journal on Addictions, 2008. Vol. 17, no. 3, pp. 167–171. DOI:10.1080/10550490802019642
12. Clegg-Kraynok M.M., McBean A.L., Montgomery-Downs H.E. Sleep quality and characteristics of college students who use prescription psychostimulants nonmedically. Sleep Medicine, 2011. Vol. 12, no. 6, pp. 598–602. DOI:10.1016/j.sleep.2011.01.012
13. Kudlow P.A. et al. Cognitive Enhancement in Canadian Medical Students. Journal of psychoactive drugs, 2013. Vol. 45, no. 4, pp. 360–365. DOI:10.1080/02791072.2013.825033
14. DeSantis A.D., Anthony K.E., Cohen E.L. Illegal college ADHD stimulant distributors: characteristics and potential areas of intervention. Substance use & misuse, 2013. Vol. 48, pp. 446–456. DOI:10.3109/10826084.2013.778281
15. DeSantis A.D., Webb E.M., Noar S.M. Illicit use of prescription ADHD medications on a college campus: A multimethological approach. Journal of American college health, 2008. Vol. 57, no. 3, pp. 315–323. DOI:10.3200/JACH.57.3.315-324
16. Arria A.M. et al. Do college students improve their grades by using prescription stimulants nonmedically? Addictive Behaviors, 2017. Vol. 65, pp. 245–249. DOI:10.1016/j.addbeh.2016.07.016
17. McCabe S.E. et al. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction, 2007. Vol. 102, no. 12, pp. 1920–1930. DOI:10.1111/j.1360-0443.2007.02015.x
18. Farah M. The Unknowns of Cognitive Enhancement. Science, 2015. Vol. 350, pp. 379–380. DOI:10.1126/science.aad5893
19. Global drug survey 2016 [Elektronnyi resurs]. Global drug survey, 2016. URL: https://www.globaldrugsurvey.com/wp-content/uploads/2016/06/TASTER-KEY-FINDINGS-FROM-GDS2016.pdf (Accessed 10.06.2021).
20. Dresler M. et al. Hacking the Brain: Dimensions of Cognitive Enhancement. ACS chemical neuroscience, 2019. Vol. 10, no. 3, pp. 1137–1148. DOI:10.1021/acschemneuro.8b00571
21. Pham T. et al. Household diversion of prescription stimulants: medication misuse by parents of children with attention-deficit/hyperactivity disorder. Journal of child and adolescent psychopharmacology, 2017. Vol. 27, no. 8, pp. 741–746. DOI:10.1089/cap.2016.0058
22. Hupli A., Didziokaite G., Ydema M. Toward the Smarter Use of Smart Drugs: Perceptions and Experiences of University Students in the Netherlands and Lithuania. Contemporary Drug Problems, 2016. Vol. 43, no. 3, pp. 242–257. DOI:10.1177/0091450916660143
23. Sattler S. et al. Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS ONE, 2013. Vol. 8, no. 8, article ID e7145, 12 p. DOI:10.1371/journal.pone.0071452
24. Rozenek E.B. et al. In search of optimal psychoactivation: stimulants as cognitive performance enhancers. Archives of Industrial Hygiene and Toxicology, 2019. Vol. 70, pp. 150–159. DOI:10.2478/aiht-2019-70-3298
25. Lautieri A.B.A. Long-Term Effects of Heavy Adderall Use [Elektronnyi resurs]. American Addiction Centers, 2017. URL: https://americanaddictioncenters.org/adderall/long-term-effects/ (Accessed 10.06.2021).
26. Lengvenyte A., Strumila R., Grikiniene J. Use of cognitive enhancers among medical students in Lithuania. Nordic Studies on Alcohol and Drugs, 2016. Vol. 33, no. 2, pp. 173–188. DOI:10.1515/nsad-2016-0014
27. León K.S., Martínez D.E. To Study, to Party, or Both? Assessing Risk Factors for Non-Prescribed Stimulant Use Among Middle and High School Students. Journal of psychoactive drugs, 2017. Vol. 49, no. 1, pp. 22–30. DOI:10.1080/02791072.2016.1260187
28. Low K.G., Gendaszek A.E. Illicit use of psychostimulants among college students: A preliminary study. Psychology, Health & Medicine, 2002. Vol. 7, no. 3, pp. 283–287. DOI:10.1080/13548500220139386
29. Maier L.J., Ferris J.A., Winstock A.R. Pharmacological cognitive enhancement among non-ADHD individuals—a cross-sectional study in 15 countries. International Journal of Drug Policy, 2018. Vol. 58, pp. 104–112. DOI:10.1016/j.drugpo.2018.05.009
30. McCabe S.E., Teter C.J., Boyd C.J. Medical use, illicit use and diversion of prescription stimulant medication. Journal of psychoactive drugs, 2006. Vol. 38, no. 1, pp. 43–56. DOI:10.1080/02791072.2006.10399827
31. Measham F., Shiner M. The legacy of 'Normalisation': the role of classical and contemporary criminological theory in understanding young people's drug use. International journal of drug policy, 2009. Vol. 20, no. 6, pp. 502–508. DOI:10.1016/j.drugpo.2009.02.001
32. Orsolini L. et al. Mind navigators of chemicals’ experimenters? A web-based description of e-psychonauts. Cyberpsychology, Behavior, and Social Networking, 2015. Vol. 18, pp. 296–300. DOI:10.1089/cyber.2014.0486
33. Fond G. et al. (Mis)use of prescribed stimulants in the medical student community: Motives and behaviors. A population-based cross-sectional study. Medicine, 2016. Vol. 95, no. 16, article ID e3366, 8 p. DOI:10.1097/MD.0000000000003366
34. Weyandt L.L. et al. Misuse of prescription stimulants among college students: A review of the literature and implications for morphological and cognitive effects on brain functioning. Experimental and Clinical Psychopharmacology, 2013. Vol. 21, no. 5, pp. 385–407. DOI:10.1037/a0034013
35. Benson K. et al. Misuse of Stimulant Medication Among College Students: A Comprehensive Review and Meta-analysis. Clinical child and family psychology review, 2015. Vol. 18, pp. 50–76. DOI:10.1007/s10567-014-0177-z
36. Cropsey K.L. et al. Mixed-amphetamine salts expectancies among college students: Is stimulant induced cognitive enhancement a placebo effect? Drug Alcohol Depend, 2017. Vol. 178, pp. 302−309. DOI:10.1016/j.drugalcdep.2017.05.024
37. Repantis D. et al. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological research, 2010. Vol. 62, no. 3, pp. 187–206. DOI:10.1016/j.phrs.2010.04.002
38. Johnston L.D. et al. Monitoring the Future: National survey results on drug use, 1975–2015. Volume 2: college students and adults ages 19–55 [Elektronnyi resurs]. Michigan: The University of Michigan, 2016. 455 p. URL: https://deepblue.lib.umich.edu/bitstream/handle/2027.42/137906/mtf-vol2_2015.pdf (Accessed 10.06.2021).
39. Eickenhorst P. et al. Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs. Journal of psychoactive drugs, 2012. Vol. 44, no. 5, pp. 418–427. DOI:10.1080/02791072.2012.736845
40. Arria A.M. et al. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy, 2008. Vol. 28, no. 2, pp. 156–169. DOI:10.1592/phco.28.2.156
41. McCabe S.E. et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction, 2005. Vol. 100, no. 1, pp. 96–106. DOI:10.1111/j.1360-0443.2005.00944.x
42. Nootropics Market Size, Share & Trends Analysis Report By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Anxiety), By Distribution Channel, And Segment Forecasts, 2019–2025 [Elektronnyi resurs]. Marketysers Global Consulting LLP, 2021. URL: https://www.reportsanddata.com/report-detail/nootropics-market (Accessed 10.06.2021).
43. Arria A.M. et al. Perceived academic benefit is associated with nonmedical prescription stimulant use among college students. Addictive behaviors, 2018. Vol. 76, pp. 27–33. DOI:10.1016/j.addbeh.2017.07.013
44. Carton L. et al. Pharmaceutical cognitive doping in students: A chimeric way to get-a-head? Therapie, 2018. Vol. 73, no. 4, pp. 331–339. DOI:10.1016/j.therap.2018.02.005
45. Phillips E.L., McDaniel A.E. College prescription drug study: key findings report [Elektronnyi resurs]. Columbus, OH: Center for the Study of Student Life, Ohio State University; 2018. 12 p. URL: https://cssl.osu.edu/posts/632320bc-704d-4eef-8bcb-87c83019f2e9/documents/cpds-key-findings-2018.pdf (Accessed 10.06.2021).
46. Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use [Elektronnyi resurs]. CMAJ, 2001. Vol. 165, no. 8, pp. 1039–1044. URL: https://www.cmaj.ca/content/cmaj/165/8/1039.full.pdf (Accessed 10.06.2021).
47. Teter C.J. et al. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American college health, 2005. Vol. 53, no. 6, pp. 253–262. DOI:10.3200/JACH.53.6.253-262
48. Dietz P. et al. Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets. Frontiers in pharmacology, 2018. Vol. 9, article ID 494, 9 p. DOI:10.3389/fphar.2018.00494
49. Report of the International Narcotics Control Board for 2019 (Russian language) [Elektronnyi resurs]. Vienna: United Nations, 2020, pp. 146. URL: https://www.incb.org/documents/Publications/AnnualReports/AR2019/Annual_Report/English_ebook_AR2019.pdf (Accessed 10.06.2021).
50. Results from the 2015 National Survey on Drug Use and Health: Detailed tables [Elektronnyi resurs]. Substance Abuse and Mental Health Services Administration. Rockville, MD: US Department of Health and Human Services, Office of Applied Studies. 2016. URL: https://www.samhsa.gov/data/sites/default/files/reports/rpt29394/NSDUHDetailedTabs2019/NSDUHDetTabsAppA2019.htm (Accessed 10.06.2021).
51. Smith M.F., Farah M.J. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological bulletin, 2011. Vol. 137, no. 5, pp. 717–741. DOI:10.1037/a0023825
52. Faraone S.V. et al. Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies. Journal of the American Academy of Child & Adolescent Psychiatry, 2020. Vol. 59, no. 1, pp. 100–112. DOI:10.1016/j.jaac.2019.06.012
53. Novak S.P. et al. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Substance abuse treatment, prevention, and policy, 2007. Vol. 2, no. 32, 17 p. DOI:10.1186/1747-597X-2-32
54. Droste N. et al. The right place at the right time: The social contexts of combined alcohol and energy drink use. Drugs: Education, Prevention and Policy, 2016. Vol. 23, no. 6, pp. 445–456. DOI:10.3109/09687637.2016.1156650
55. Maier L.J. et al. To dope or not to dope: Neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS ONE, 2013. Vol. 8, no. 11, 10 p. DOI:10.1371/journal.pone.0077967
56. Greely H. et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 2008. Vol. 456, pp. 702–705. DOI:10.1038/456702a
57. Alonso J. et al. Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries. Depression and anxiety, 2018. Vol. 35, no. 3, pp. 195–208. DOI:10.1002/da.22711
58. Pighi M. et al. Use and Propensity to Use Substances as Cognitive Enhancers in Italian Medical Students. Brain sciences, 2018. Vol. 8, no. 11, 9 p. DOI:10.3390/brainsci8110197
59. Zaami S. et al. Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue. Frontiers in psychiatry, 2020. Vol. 10, article ID 1006, 3 p. DOI:10.3389/fpsyt.2019.01006
60. Vo K., Neafsey P., Lin C. Concurrent use of amphetamine stimulants and antidepressants by undergraduate students. Patient preference and adherence, 2015. Vol. 9, pp. 161–172. DOI:10.2147/PPA.S74602
61. Watson G.L., Arcona A.P., Antonuccio D.O. The ADHD drug abuse crisis on American college campuses [Elektronnyi resurs]. Ethical Hum Psychol Psychiatry, 2015. Vol. 17, pp. 5–21. URL: https://www.academia.edu/download/40008273/ADHD_Drug_Abuse_Crisis_2015_EHPP_171.pdf (Accessed 10.06.2021).